University of Erlangen-Nuremberg

About: University of Erlangen-Nuremberg is a education organization based out in Erlangen, Bayern, Germany. It is known for research contribution in the topics: Population & Immune system. The organization has 42405 authors who have published 85600 publications receiving 2663922 citations.

Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis

Abstract: PURPOSE. To analyze whether bevacizumab can inhibit inflammatory angiogenesis and lymphangiogenesis in the cornea. Bevacizumab (Avastin; Roche, Welwyn Garden City, UK) is a recombinant, humanized, monoclonal antibody against VEGF-A that has been approved by the U.S. Food and Drug Administration for the treatment of colon carcinomas. METHODS. The mouse model of suture-induced corneal neovascularization was used to assess the antihemangiogenic and antilymphangiogenic effect of bevacizumab by systemic and topical application. Corneal flatmounts were stained with LYVE-1 as a specific lymphatic vascular endothelial marker and CD31 as a pan-endothelial marker, and blood and lymph vascularized areas were analyzed morphometrically. The inhibitory effect of bevacizumab on lymphatic endothelial cells (LECs) was analyzed with a colorimetric (BrdU) proliferation ELISA. The binding ability of bevacizumab to murine VEGF-A was analyzed by Western blot, ELISA, and surface plasmon resonance. RESULTS. The systemic and topical applications of bevacizumab significantly inhibited the outgrowth of blood (P 0.006 and P 0.0001, respectively) and lymphatic (P 0.002 and P 0.0001, respectively) vessels. Inhibition of the proliferation of LECs was also significant (P 0.0001). Western blot analysis, ELISA, and the surface plasmon resonance assay showed that bevacizumab binds murine VEGF-A. CONCLUSIONS. Topical or systemic application of bevacizumab inhibits both inflammation-induced angiogenesis and lymphangiogenesis in the cornea. This finding suggests an important role of VEGF-A in corneal lymphangiogenesis. Bevacizumab may be useful in preventing immune rejections after penetrating keratoplasty or tumor metastasis via lymphatic vessels. (Invest Ophthalmol Vis Sci. 2007;48:2545‐2552) DOI:

Improved total variation-based CT image reconstruction applied to clinical data

Abstract: In computed tomography there are different situations where reconstruction has to be performed with limited raw data. In the past few years it has been shown that algorithms which are based on compressed sensing theory are able to handle incomplete datasets quite well. As a cost function these algorithms use the l(1)-norm of the image after it has been transformed by a sparsifying transformation. This yields to an inequality-constrained convex optimization problem. Due to the large size of the optimization problem some heuristic optimization algorithms have been proposed in the past few years. The most popular way is optimizing the raw data and sparsity cost functions separately in an alternating manner. In this paper we will follow this strategy and present a new method to adapt these optimization steps. Compared to existing methods which perform similarly, the proposed method needs no a priori knowledge about the raw data consistency. It is ensured that the algorithm converges to the lowest possible value of the raw data cost function, while holding the sparsity constraint at a low value. This is achieved by transferring the step-size determination of both optimization procedures into the raw data domain, where they are adapted to each other. To evaluate the algorithm, we process measured clinical datasets. To cover a wide field of possible applications, we focus on the problems of angular undersampling, data lost due to metal implants, limited view angle tomography and interior tomography. In all cases the presented method reaches convergence within less than 25 iteration steps, while using a constant set of algorithm control parameters. The image artifacts caused by incomplete raw data are mostly removed without introducing new effects like staircasing. All scenarios are compared to an existing implementation of the ASD-POCS algorithm, which realizes the step-size adaption in a different way. Additional prior information as proposed by the PICCS algorithm can be incorporated easily into the optimization process.

Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.

Abstract: Nitric oxide (NO) synthase (iNOS) is required for the resolution of acute cutaneous leishmaniasis in resistant C57BL/6 mice. As is the case in several other infections, the clinically cured host organism still harbors small amounts of live Leishmania major parasites. Here, we demonstrate lifelong expression of iNOS at the site of the original skin lesion and in the draining lymph node of long-term-infected C57BL/6 mice. iNOS activity in the lymph node was dependent on CD4+, but not on the CD8+ T cells. By double labeling techniques, iNOS and L. major were each found in macrophages (F4/80+, BM-8+, and/or MOMA-2+) and dendritic cells (NLDC-145+), but not in granulocytes or endothelial cells. In situ triple labeling of lymph node sections revealed that approximately 30-40% of the L. major foci were associated with iNOS-positive macrophages or dendritic cells. The majority of the L. major foci (60-70%), however, was located in areas that were negative for both iNOS and the macrophage and dendritic cell markers. In L. major-infected C57BL/6 mice, which had cured their cutaneous lesions, administration of L-N6-iminoethyl-lysine (L-NIL), a potent inhibitor of iNOS, led to a 10(4)-10(5)-fold increase of the parasite burden in the cutaneous and lymphoid tissue and caused clinical recrudescence of the disease. Persistent expression of iNOS and resumption of parasite replication after application of L-NIL was also observed in resistant C3H/HeN and CBA/J mice. We conclude that iNOS activity is crucial for the control of Leishmania persisting in immunocompetent hosts after resolution of the primary infection. Failure to maintain iNOS activity might be the mechanism underlying endogenous reactivation of latent infections with NO-sensitive microbes during phases of immunosuppression.

Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial

Abstract: Purpose We previously described the prognostic impact of tumor regression grading (TRG) on the outcome of patients with rectal carcinoma treated with preoperative chemoradiotherapy (CRT) in the CAO/ARO/AIO-94 trial. Here we report long-term results after a median follow-up of 132 months.

Observation of optical polarization Möbius strips

Abstract: Mobius strips are three-dimensional geometrical structures, fascinating for their peculiar property of being surfaces with only one “side” - or, more technically, being “non-orientable” surfaces. Despite being easily realized artificially, the spontaneous emergence of these structures in nature is exceedingly rare. Here, we generate Mobius strips of optical polarization by tightly focusing the light beam emerging from a q -plate, a liquid crystal device that modifies the polarization of light in a space-variant manner. Using a recently developed method for the three-dimensional nano-tomography of optical vector fields, we fully reconstruct the light polarization structure in the focal region, confirming the appearance of Mobius polarization structures. The preparation of such structured light modes may be important for complex light beam engineering and optical micro- and nano-fabrication.